Concepedia

Martin S. Linsell

MS

Statistics

Publications

12

Citations

827

H-Index

12

Active since

1998

Affiliations

Theravance Biopharma (United States)(Current)

Université de Montréal

Martin S. Linsell is an author at Theravance Biopharma (United States) specializing in medicinal chemistry, drug discovery, and drug design.

Publications per year

1998–2019

12

Publications

12

Synthesis and Spectrum of the Neoglycoside ACHN-490

James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum et al. · Antimicrobial Agents and Chemotherapy · 2010 · 241 citations · Full text

, , +17

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 164 citations · Full text

, , +10

Multivalent Drug Design. Synthesis and In Vitro Analysis of an Array of Vancomycin Dimers

John H. Griffin, Martin S. Linsell, Matthew B. Nodwell et al. · Journal of the American Chemical Society · 2003 · 77 citations

, , +14

Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety

Frederick Cohen, James B. Aggen, Logan D. Andrews et al. · ChemMedChem · 2019 · 76 citations

, , +16

Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers

Daniel D. Long, James B. Aggen, Jason Chinn et al. · The Journal of Antibiotics · 2008 · 58 citations

, , +10

1–5 of 12